Verastem | VSTM - Current Liabilities

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $35.62M in Current Liabilities for its fiscal quarter ending in March of 2025.





Current Liabilities Change Date
AbbVie USD 39.39B 376M Sep/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Curis USD 19.37M 745K Jun/2025
Cytokinetics USD 142.14M 11.08M Sep/2025
Gilead Sciences USD 11.81B 485M Dec/2025
Incyte USD 1.52B 176.44M Dec/2025
Laboratory Of America USD 2.63B 87.6M Sep/2025
Novartis USD 32B 286M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Roche Holding CHF 28B 421M Dec/2025
TG Therapeutics USD 156.81M 15.08M Sep/2025
Verastem USD 35.62M 4.65M Mar/2025